Leonard Schleifer (Photo by: Adam Jeffery/CNBC/NBCU Photo Bank via Getty Images)

Re­gen­eron inks $1B+ deal for glob­al rights to Sanofi-part­nered PD-1 Lib­tayo

Sanofi CEO Paul Hud­son made clear ear­li­er this year that his mis­sion to re­shape the com­pa­ny would in­volve some pipeline prun­ing. For the right price …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland